CatalystPit

CRVOCervoMed Inc.

NASDAQ · Pharmaceutical Preparations
Last close $2.97 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$44.90M
RECENT INSIDER TRADES
  • 2026-06-15 · BOGER JOSHUA S (Director) · BUY
  • 2025-11-19 · Winton Matthew (Chief Commercial and Business) · BUY
  • 2025-11-19 · ELDER WILLIAM ROBERT (CFO, GC & Secretary) · BUY
INSTITUTIONAL OWNERSHIP
Institutional holders42
Shares held2,473,727
Value$13.61M
Percent of shares outstanding16.36%
As of quarter end2026-06-30
RECENT NEWS
  • H.C. Wainwright reiterates Buy on CervoMed stock on new formulation
  • CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit
  • CervoMed to participate in ROTH Healthcare Opportunities Conference
  • CervoMed Inc. · 8-K (7.01,8.01,9.01)
  • CervoMed Phase 2a neflamapimod trial results accepted for ISFTD 2026
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
CervoMed Inc. (CRVO) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit